Unknown

Dataset Information

0

Albumin-EDTA-Vanadium Is a Powerful Anti-Proliferative Agent, Following Entrance into Glioma Cells via Caveolae-Mediated Endocytosis.


ABSTRACT: Human serum albumin (HSA) is efficiently taken up by cancer cells as a source of carbon and energy. In this study, we prepared a monomodified derivative of HSA covalently linked to an EDTA derivative and investigated its efficacy to shuttle weakly anti-proliferative EDTA associating ligands such as vanadium, into a cancer cell line. HSA-S-MAL-(CH2)2-NH-CO-EDTA was found to associate both with the vanadium anion (+5) and the vanadium cation (+4) with more than thrice the associating affinity of those ligands toward EDTA. Both conjugates internalized into glioma tumor cell line via caveolae-mediated endocytosis pathway and showed potent anti-proliferative capacities. IC50 values were in the range of 0.2 to 0.3 µM, potentiating the anti-proliferative efficacies of vanadium (+4) and vanadium (+5) twenty to thirty fold, respectively. HSA-EDTA-VO++ in particular is a cancer permeable prodrug conjugate. The associated vanadium (+4) is not released, nor is it active anti-proliferatively prior to its engagement with the cancerous cells. The bound vanadium (+4) dissociates from the conjugate under acidic conditions with half maximal value at pH 5.8. In conclusion, the anti-proliferative activity feature of vanadium can be amplified and directed toward a cancer cell line. This is accomplished using a specially designed HSA-EDTA-shuttling vehicle, enabling vanadium to be anti-proliferatively active at the low micromolar range of concentration.

SUBMITTER: Cooper I 

PROVIDER: S-EPMC8540012 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Albumin-EDTA-Vanadium Is a Powerful Anti-Proliferative Agent, Following Entrance into Glioma Cells via Caveolae-Mediated Endocytosis.

Cooper Itzik I   Ravid Orly O   Rand Daniel D   Atrakchi Dana D   Shemesh Chen C   Bresler Yael Y   Ben-Nissan Gili G   Sharon Michal M   Fridkin Mati M   Shechter Yoram Y  

Pharmaceutics 20210925 10


Human serum albumin (HSA) is efficiently taken up by cancer cells as a source of carbon and energy. In this study, we prepared a monomodified derivative of HSA covalently linked to an EDTA derivative and investigated its efficacy to shuttle weakly anti-proliferative EDTA associating ligands such as vanadium, into a cancer cell line. HSA-S-MAL-(CH<sub>2</sub>)<sub>2</sub>-NH-CO-EDTA was found to associate both with the vanadium anion (+5) and the vanadium cation (+4) with more than thrice the ass  ...[more]

Similar Datasets

| S-EPMC5668166 | biostudies-literature
| S-EPMC3787714 | biostudies-literature
| S-EPMC4390356 | biostudies-literature
| S-EPMC1196308 | biostudies-literature
| S-EPMC4600376 | biostudies-literature
| S-EPMC3979662 | biostudies-literature
| S-EPMC3912526 | biostudies-literature
| S-EPMC3522706 | biostudies-literature
| S-EPMC8950576 | biostudies-literature
| S-EPMC3659420 | biostudies-literature